Vibe5: High-Upside Bets Under $50
Five founders. Five frequencies. One signal.
We’re not scanning for price swings—we’re listening for founder frequency.
Every Monday, I drop the Vibe5: five public companies under $50 where the story cuts through the noise. This week’s picks stretch from biotech resilience to real estate reform. Let’s tune in:
🧬 23andMe (ME, $0.55)
The biotech data moat. Anne Wojcicki’s 14M DNA profiles could be the fuel for future partnerships—or a comeback story in motion…
📟 PagerDuty (PD, $16.71)
DevOps heartbeat. Jennifer Tejada leads with clarity and calm. Engineers love it. Acquirers might, too.
🔋 Amprius Technologies (AMPX, $2.74)
Batteries for drones and defense. Kang Sun is quietly charging the future—literally.
💉 Sana Biotechnology (SANA, $2.00)
Gene therapy with AI in its DNA. Steve Harr’s biotech vision is long-range, but sharp.
🏠 Redfin (RDFN, $9.18)
Real estate reformer. Glenn Kelman is timing a market that most fear—and he’s not backing down.
Five sectors. Five signals. All founder-led.
This isn’t financial advice. It’s founder frequency.
👉 Follow for weekly drops: vibevest.io
📍 On X: @vibevest_io
📸 On Instagram: @vibevest_io
Call to Action:
Dig the Vibe5?
Subscribe for weekly VibeRecs, fresh Vibe5s, Fast Fails and deep founder dives every Monday, Wednesday + Friday.
→ vibevest.substack.com